uk 68798 has been researched along with Angina Pectoris in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cobbe, SM; Dalrymple, I; Rae, AP; Sedgwick, ML | 1 |
| Cobbe, SM; Rasmussen, HS; Sedgwick, ML | 2 |
3 trial(s) available for uk 68798 and Angina Pectoris
| Article | Year |
|---|---|
Effects of the new class III antiarrhythmic drug dofetilide on the atrial and ventricular intracardiac monophasic action potential in patients with angina pectoris.
Topics: Action Potentials; Angina Pectoris; Anti-Arrhythmia Agents; Atrial Function; Cardiac Pacing, Artificial; Double-Blind Method; Electrocardiography; Humans; Male; Middle Aged; Phenethylamines; Reaction Time; Refractory Period, Electrophysiological; Sulfonamides; Ventricular Function | 1995 |
Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris.
Topics: Action Potentials; Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Atrial Function, Right; Atrioventricular Node; Cardiac Pacing, Artificial; Double-Blind Method; Electrocardiography; Humans; Male; Middle Aged; Myocardial Contraction; Phenethylamines; Placebos; Refractory Period, Electrophysiological; Sulfonamides; Ventricular Function, Right | 1992 |
Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris.
Topics: Adult; Analysis of Variance; Angina Pectoris; Anti-Arrhythmia Agents; Double-Blind Method; Electrocardiography; Female; Heart Conduction System; Humans; Infusions, Intravenous; Linear Models; Male; Middle Aged; Phenethylamines; Random Allocation; Sulfonamides | 1992 |